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c Miltenyi Biotec, GmbH, Bergisch Gladbach, GermanyThe DNA isolation kit, whichwas used for the HIV-1 integrant assay,
extracts circular and linear unintegrated viral cDNA forms along with
cellular genomic DNA. All of these viral DNA species were detected by
the primers used in our real time quantitative PCR assay. Therefore, the
previously reported data reﬂect total cell-associated HIV cDNA copies
and not solely the integrated form. To correct this, remaining aliquots of
the original extracted DNA samples were reanalyzed following high
molecular weight physical separation, using a gel extraction procedure.
The results are presented in corrected Fig. 3A, Fig. 4, and Table 2. While
the absolute numbers of integrant copies are lower than the previously
reported, total cell-associatedHIV copies, the conclusion drawn remains
unchanged: CD44MicroBead treatment of virus, prior to T cell infection,
yields greater numbers of integrants than does infectionwith untreated
virus preparations. The new data also support our ﬁnding of greatly
increased levels of total viral cDNA sequences in cells infectedwith virus
which had been exposed to CD44 MicroBeads, indicating either
improved intracellular delivery of virus particles or higher rates of
reverse transcription. The lack of detectable integrants in samples from
cells infected with the primary isolate, 98IN017 (Fig. 3A), despite the
presence of large amounts of detectable viral cDNA, may be due to
slower viral integration kinetics, or the use of PCR primers directed
toward pol instead of gag.
Table 2. Single-cycle infection, HIV cDNA detection assay with
CD44 and CD45 reagents.a
No sample had detectable integrated copies above the assay's 10
copy detection limit.
Materials and methods
Viral integrant assay
DNAwas preparedwith the Qiagen Blood and Cell Culture DNAMini
kit according to kit instructions (Qiagen, Valencia, CA). To physicallyDOI of original article: 10.1016/j.virol.2009.03.022.
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viral cDNA, up to 2 μg of sample DNA were run on a 0.5% low melt
agarose (Genessee Scientiﬁc, Inc., San Diego, CA) TAE (Invitrogen,
Carlsbad, CA) gel at 60 V for 4 h. DNA bands at least 23 kbp in size were
excised with Gene Capsule devices (G-Biosciences, Maryland Heights,
MO), melted at 70 °C for 5 min, cooled to 42 °C for 5 min, then digested
with beta-agarase (Fermentas, Glen Burnie, MD) at 42 °C for 30 min.
Samples were extracted once with one volume of equilibrated phenol
(USB, Cleveland, OH), once with 25:24:1 phenol:chloroform:isoamyl
alcohol (USB), and twice with chloroform (Sigma Chemical Company).
DNA was precipitated with 20 μg glycogen (Fermentas), 0.2 volumes
3 M sodium acetate, pH 5.2 (Teknova, Hollister, CA), and 2 volumes
absolute ethanol at −20 °C overnight or −80 °C for at least 30 min.
DNAwas pelleted and washed twice with 70% ethanol, air dried brieﬂy,
then resuspended in 25 μl 10 mMTris, pH 8. DNA sampleswere assayed
by TaqMan real-time PCR for genomic cellular input with RNAseP
primers andVIC-labeled probe (Applied Biosystems, Inc., Foster City, IA)
multiplexed with HIV-1 pol primers and FAM labeled probe originally
designed by Althaus, et al. (2010, 2011): forward mf299 5′-GCACTT-
TAAATTTTCCCATTAGTCCTA-3′, reverse mf302 5′-CAAATTTCTACTAAT
GCTTTTATTTTTTC-3′, probe mf348 5′-/56-FAM/AAGCCAGGAATG-
GATGGCC/3BHQ-1/-3′, and synthesized by Integrated DNA Technolo-
gies (Coralville, IA). 2LTR circles were quantiﬁed with the following
primers (Butler et al., 2001): forward 5′-AACTAGGGAACCCACTGCT-
TAAG-3′, reverse 5′-TCCACAGATCAAGGATATCTTGTC-3′, probe 5′-/56-
FAM/ACACTACTTGAAGCACTCAAGGCAAGCTTT/3BHQ-1/-3′. Standard
curves were generated with genomic DNA from healthy human PBMC
(RNaseP) and linearized pNL-EGFP plasmid (pol), diluted into a back-
ground of 1 μg of herring sperm DNA (Promega, Madison, WI), or
pG2LTR plasmid (Yoder and Fishel, 2008) in 200 ng of uninfected CD4
cell genomicDNA (2LTR circle). HIV-1 pol copynumberswere corrected
for 2LTR circle copuriﬁcation, adjusted for the amount of inputDNA, and
expressed as copies/200 ng DNA.
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Fig. 3. Enhanced infection results in higher levels of HIV integrants and replication
competent infected cell units. (A). Primary CD4 cells were infected with the R5 clone, JR-
CSF (left panels) or cladeC,X4 isolate 98IN017 (rightpanels)withorwithout pretreatment
with CD44MicroBeads. At the end of 2 weeks of culture, genomic DNAwas isolated by gel
separation for qPCR quantiﬁcation of HIV integrants per 200 ng input DNA. Results from
three independent cell donors shown (x axis: A, B, C). The detection limit for these assays
ranged from 5 to 20 copies per PCR run. *Below detection limit.
Fig. 4. CD44MicroBead treatment increases HIV integration during ﬁrst-cycle infection.
HIV integrants per 200 ng input DNA were quantiﬁed after a 6 h infection followed by
an 18 h incubation, with or without TCR/CD28 stimulation. Results from two
independent cell donors (A, B). There was insufﬁcient DNA from Donor C to analyze.
The detection limit for these assays was 10 copies per PCR. *Below detection limit.
